{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T20:47:43Z","timestamp":1762375663597},"reference-count":20,"publisher":"Frontiers Media SA","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1023,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1111\/j.1432-2277.2012.01570.x","type":"journal-article","created":{"date-parts":[[2012,11,12]],"date-time":"2012-11-12T12:01:07Z","timestamp":1352721667000},"page":"34-41","source":"Crossref","is-referenced-by-count":17,"title":["Antithymocyte globulin induction therapy improves survival in lung transplantation for cystic fibrosis"],"prefix":"10.3389","volume":"26","author":[{"given":"Peter","family":"Jaksch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Wiedemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Murak\u00f6zy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Scheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred A.","family":"Kocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Klepetko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2012,11,12]]},"reference":[{"key":"10.1111\/j.1432-2277.2012.01570.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/s-2006-954604","article-title":"Overview of lung transplantation and criteria for selection of candidates","volume":"27","author":"Lynch","year":"2006","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1111\/j.1432-2277.2012.01570.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MCP.0b013e32834b8bdb","article-title":"Cystic fibrosis lung transplantation","volume":"17","author":"Braun","year":"2011","journal-title":"Curr Opin Pulm Med"},{"key":"10.1111\/j.1432-2277.2012.01570.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.healun.2011.08.004","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report - 2011","volume":"30","author":"Christie","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1432-2277.2012.01570.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/MOT.0b013e32831040bf","article-title":"Evidence for immunosuppression in lung transplantation","volume":"13","author":"Hopkins","year":"2008","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1111\/j.1432-2277.2012.01570.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1513\/pats.200808-096GO","article-title":"Immunosuppression for lung transplantation","volume":"6","author":"Bhorade","year":"2009","journal-title":"Proc Am Thorac Soc"},{"key":"10.1111\/j.1432-2277.2012.01570.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/0003-4975(92)90635-H","article-title":"Acute rejection of lung allografts with various immunosuppressive protocols","volume":"54","author":"Griffith","year":"1992","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/j.1432-2277.2012.01570.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1378\/chest.116.1.127","article-title":"Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study","volume":"116","author":"Palmer","year":"1999","journal-title":"Chest"},{"key":"10.1111\/j.1432-2277.2012.01570.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00007890-200103270-00015","article-title":"Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody","volume":"71","author":"Garrity","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01570.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/01.TP.0000056635.59888.EF","article-title":"A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients","volume":"75","author":"Charpentier","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01570.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/00007890-200210270-00008","article-title":"Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients","volume":"74","author":"Duvoux","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01570.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","article-title":"Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection","volume":"26","author":"Stewart","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1432-2277.2012.01570.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.healun.2004.09.002","article-title":"A comparison of basiliximab and anti-thymocyte globulin as induction agents after lung transplantation","volume":"24","author":"Hachem","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1432-2277.2012.01570.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1164\/ajrccm.185.1.108a","article-title":"Interleukin-17 and cystic fibrosis lung disease","volume":"185","author":"Brodlie","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1432-2277.2012.01570.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1164\/rccm.201102-0236OC","article-title":"The Th17 pathway in cystic fibrosis lung disease","volume":"184","author":"Tan","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1432-2277.2012.01570.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccm.2011.02.009","article-title":"Chronic allograft dysfunction","volume":"32","author":"Knoop","year":"2011","journal-title":"Clin Chest Med"},{"key":"10.1111\/j.1432-2277.2012.01570.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1600-6143.2011.03837.x","article-title":"Is prevention the best treatment? CMV after lung transplantation","volume":"12","author":"Patel","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01570.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.transproceed.2011.02.069","article-title":"Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation","volume":"43","author":"Snydman","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2012.01570.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1378\/chest.06-1163","article-title":"Special considerations for patients with cystic fibrosis undergoing lung transplantation","volume":"131","author":"Hadjiliadis","year":"2007","journal-title":"Chest"},{"key":"10.1111\/j.1432-2277.2012.01570.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003495-200666040-00003","article-title":"Post-transplant lymphoproliferative disease: association with induction therapy?","volume":"66","author":"Dharnidharka","year":"2006","journal-title":"Drugs"},{"key":"10.1111\/j.1432-2277.2012.01570.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1399-3046.2005.00361.x","article-title":"Risk for post-transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation","volume":"9","author":"Dharnidharka","year":"2005","journal-title":"Pediatr Transplant"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1432-2277.2012.01570.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1432-2277.2012.01570.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T05:00:58Z","timestamp":1643605258000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1432-2277.2012.01570.x"}},"subtitle":["Benefit of induction therapy in LuTX CF patients"],"short-title":[],"issued":{"date-parts":[[2012,11,12]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1432-2277.2012.01570.x","relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11,12]]}}}